Learn more
Webcast featuring eSpOT-ON
Cart
Account
Your Orders
Sign In
My Cart
Products
CRISPR NUCLEASES
Cutting-edge CRISPR nucleases for therapeutic applications.
hfCas12Max
→
Research SpCas9
→
eSpOT-ON Protein
→
eSpOT-ON mRNA
→
Accubase
→
GMP SpCas9
→
CRISPR gRNA
Best-in-class gRNA that provides you the flexibility and scalability you need for therapeutic development.
Research sgRNA
→
GMP sgRNA
→
CRISPR gRNA Controls
→
Gene Knockout Kits from EditCo.bio
→
RNA ENZYMES
Protect your RNA workflows with reliable and efficient essential RNA enzymes.
T7 RNA Polymerase
→
RNase Inhibitor
→
CRISPR Solutions
FROM RUO TO GMP
Explore CRISPR Continuum
→
Let us be your Guide from early discovery to clinical application
CRISPR Clinical Solutions
→
True GMP CRISPR Solutions with Proven Success
CRISPR Nucleases
→
Cutting-Edge CRISPR Nucleases For Therapeutic Applications
NAVIGATE REGULATORY LANDSCAPE
Regulatory Expertise
→
Expert guidance for navigating IND submissions and early clinical trials.
IMPROVE RNA SYNTHESIS
Essential IVT Enzymes
→
Explore high-quality IVT enzymes for RNA synthesis and therapeutics
BIOINFORMATICS TOOLS
Fast and easy CRISPR gRNA design tool and validate your gRNA.
CRISPR Design Tool
→
CRISPR Validation Tool
→
ANALYZE CRISPR EDITS
ICE CRISPR Analysis Tool
→
Learn
ABOUT CRISPR
What Is CRISPR
→
How To Use CRISPR Guide
→
CRISPR Methods
→
Gene Editing History
→
Other Genome Editing Tools And Applications
→
CRISPR APPLICATIONS
Base Editing
→
Sickle Cell
→
CAR-T Cell Therapy
→
Cancer
→
Primary Cells
→
iPS Cells
→
RESOURCE LIBRARY
Protocols
→
Application Notes
→
Case Studies
→
Videos
→
eBooks
→
CRISPR IN ACTION
Articles from the Bench
→
Publications
→
Company
About
→
Newsroom
→
Careers
→
Partner With Us
→
Testimonials
→
Support
Watch Ordering Video
→
Help
→
Protocols
→
Contact
→
Order
Test
→
Research sgRNA
→
hfCas12Max Nuclease
→
SpCas9 Nuclease
→
gRNA Control
→
Your Account
Cart
→
Account
→
Edit Credit
→
Your Orders
→
Sign In
→
Sign Out
→
Contact Sales
You are in a distributor managed country, to make orders please contact your local distributor
Contact Distributor
×
Newsroom
Stay Connected with Our Latest News and Media Assets
Contact Us
Download Synthego Logo
Showing 12 of 105
Synthego Announces Successful Close of Acquisition by Perceptive Advisors
Jul 21, 2025
Synthego Gains Approval to Proceed with Sale to Perceptive Advisors; Transaction Set to Close in July
Jun 26, 2025
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid
Jun 12, 2025
Synthego Introduces GMP SpCas9 to Accelerate Gene Editing for Therapeutic Advancement
May 12, 2025
Synthego Initiates Strategic Financial Restructuring to Facilitate Sale, Reduce Debt, Strengthen Balance Sheet
May 5, 2025
Synthego and Vita Therapeutics Announce Strategic Licensing Agreement for hfCas12Max CRISPR Nuclease
Apr 8, 2025
AstraZeneca, Synthego ink gene editing enzyme licensing deal
Jan 13, 2025
Synthego Signs Strategic Agreement with AstraZeneca to License CRISPR Gene Editing Enzyme eSpOT-ON
Jan 13, 2025
Synthego Launches High-Value IVT Enzymes for Advanced RNA Therapeutics
Nov 4, 2024
Synthego Launches hfCas12Max High-Fidelity CRISPR Enzyme for Therapeutic Development
Jun 3, 2024
EditCo Bio and Telegraph Hill Partners Acquire Synthego’s Engineered Cell Solutions Business to Enable Cellular Research
Mar 27, 2024
Synthego Announces CEO Transition to Focus on Enabling CRISPR Therapeutics
Mar 27, 2024
Cart
Account
Your Orders
Sign In